Defining goals for molecular remission in Chronic Myeloid Leukemia.
Elias Jabbour, MD University of Texas – M. D. Anderson Cancer Center CML and Imatinib Resistance: Which TKI and When?
Elias Jabbour, MD University of Texas – M. D. Anderson Cancer Center
